Jeremy L. Stigall - Jun 10, 2022 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role
GM, Biologics & Drug Delivery
Signature
/s/ Richard F. Mattern by Power of Attorney for Jeremy L. Stigall
Stock symbol
CLPT
Transactions as of
Jun 10, 2022
Transactions value $
$0
Form type
4
Date filed
6/14/2022, 04:15 PM
Previous filing
May 19, 2022
Next filing
Jul 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLPT Common Stock Award $0 +17.5K +68.25% $0.00 43.2K Jun 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLPT Stock Option (Right to Buy) Award $0 +11.7K $0.00 11.7K Jun 10, 2022 Common Stock 11.7K $11.41 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.
F2 The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.